Creatine raises brain energy levels and slows cognitive decline: study (thesciverse.org)

Article summary

A recent study found that creatine supplementation can raise brain energy levels and slow cognitive decline in early Alzheimer's patients by 30%. Creatine is a widely used supplement that has been shown to have benefits for brain function, particularly in situations of high metabolic demand. The study suggests that creatine may be a useful adjunct for depression treatment and may also have benefits for healthy adults, particularly under conditions of metabolic stress. The findings have implications for the use of creatine as a therapeutic agent for neurodegenerative diseases.

Main themes

• Creatine supplementation
• Brain energy metabolism
• Alzheimer's disease
• Cognitive function
• Depression treatment
• Neuroprotection

What commenters say

• Some users report noticeable improvements in cognitive function and mental energy when taking creatine, particularly at high doses.
• The optimal dosage of creatine for brain benefits is unclear, with some studies suggesting higher doses may be necessary to achieve significant effects.
• There is debate about the potential risks of high-dose creatine supplementation, including the impact on kidney function and the potential for dehydration.
• Some individuals report adverse effects from taking creatine, such as irritability and anxiety, while others find it has a positive impact on their mood and energy levels.
• The benefits of creatine for brain function may be particularly relevant for individuals with certain genetic mutations, such as MTHFR, or those with sleep deprivation.
• The relationship between creatine supplementation and kidney function is complex, and more research is needed to fully understand the potential risks and benefits.
• Some commenters suggest that the benefits of creatine for brain function may be due to its ability to reduce the burden on the body's methylation processes, particularly in individuals with genetic mutations.
• The use of creatine as a therapeutic agent for neurodegenerative diseases, such as Alzheimer's, is an area of ongoing research and debate.